Trial Details
COMPLETEDBasic Information
| Clinical ID | c1488 |
|---|---|
| Identifier | NCT03100864 |
| Trial Title | This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Spesolimab |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | Leuven |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-05-22 |
|---|---|
| Primary Completion Date | 2019-08-05 |
| Completion Date | 2019-10-24 |